Actelis Networks Names Dr. Hagen Hultzsch to its Technical Advisory Board

Actelis Networks Names Dr. Hagen Hultzsch to its Technical Advisory Board

Dr. Hagen Hultzsch, former member of the board of management at Deutsche Telekom AG, will provide European market expertise to the Actelis Networks Technical Advisory Board

FREMONT, Calif., January 21, 2003 - Actelis Networks®, the first company to enable fiber-quality transport services over local loop copper, announced today that Dr. Hagen Hultzsch has joined its technical advisory board.

Dr. Hultzsch's most recent position was member of the board of management at Deutsche Telekom. In this role, he was responsible for research and development, information management, information systems, process management and quality management. During Dr. Hultzsch's tenure, Deutsche Telekom evolved from a government-owned organization into a publicly owned corporation with four different business units. Prior to Deutsche Telekom, Dr. Hultzsch held various executive positions at Volkswagen AG, Electronic Data Systems (EDS) and GSI, a large German Research organization in Darmstadt. Dr. Hultzsch also served as an Assistant Professor at Mainz University and completed a fellowship at IBM's Thomas J. Watson Research Center.

"We are extremely privileged to have such a distinguished individual join our Technical Advisory Board," said Tuvia Barlev, president and chief executive officer of Actelis Networks. "Dr. Hultzsch's knowledge and experience with the European carrier market will significantly help Actelis expand our presence in that market."

"Actelis Networks value proposition is very compelling, and I'm excited about the opportunity to help expand their presence in the European market," said Dr. Hagen Hultzsch. "Actelis' MetaLIGHT® products are the type of solutions that carriers worldwide need in today's difficult market. MetaLIGHT products allow carriers to offer new and immediate revenue generating services, while keeping capital expenditures to a minimum."


Untitled Document

Leave a Reply